Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31149049)

  • 1. Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer.
    Chen CY; Wu SM; Lin YH; Chi HC; Lin SL; Yeh CT; Chuang WY; Lin KH
    Theranostics; 2019; 9(8):2361-2379. PubMed ID: 31149049
    [No Abstract]   [Full Text] [Related]  

  • 2. NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
    Emma MR; Iovanna JL; Bachvarov D; Puleio R; Loria GR; Augello G; Candido S; Libra M; Gulino A; Cancila V; McCubrey JA; Montalto G; Cervello M
    Cell Death Dis; 2016 Jun; 7(6):e2269. PubMed ID: 27336713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of microRNA-130b by thyroid hormone enhances cell motility.
    Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH
    J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of Interferon-Stimulated Gene 20 by Thyroid Hormone Enhances Angiogenesis in Liver Cancer.
    Lin SL; Wu SM; Chung IH; Lin YH; Chen CY; Chi HC; Lin TK; Yeh CT; Lin KH
    Neoplasia; 2018 Jan; 20(1):57-68. PubMed ID: 29195126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.
    Chi HC; Liao CH; Huang YH; Wu SM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Wu TI; Chen WJ; Lin KH
    Biochem Biophys Res Commun; 2013 Sep; 439(1):60-5. PubMed ID: 23958302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
    Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
    Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
    Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
    Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability.
    Lin YH; Huang YH; Wu MH; Wu SM; Chi HC; Liao CJ; Chen CY; Tseng YH; Tsai CY; Tsai MM; Lin KH
    Oncogene; 2013 Aug; 32(33):3904-14. PubMed ID: 23376845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma.
    Augello G; Emma MR; Azzolina A; Puleio R; Condorelli L; Cusimano A; Giannitrapani L; McCubrey JA; Iovanna JL; Cervello M
    Cancer Lett; 2021 Oct; 519():250-262. PubMed ID: 34314755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.
    Bak Y; Shin HJ; Bak Is; Yoon DY; Yu DY
    Biochem Biophys Res Commun; 2015 Oct; 466(4):676-81. PubMed ID: 26392315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
    Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
    Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
    Kowalik MA; Puliga E; Cabras L; Sulas P; Petrelli A; Perra A; Ledda-Columbano GM; Morandi A; Merlin S; Orrù C; Sanchez-Martin C; Fornari F; Gramantieri L; Parri M; Rasola A; Bellomo SE; Sebastian C; Follenzi A; Giordano S; Columbano A
    J Hepatol; 2020 Jun; 72(6):1159-1169. PubMed ID: 31954205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
    Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH
    Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
    Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
    BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
    Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
    Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance.
    Chung IH; Liu H; Lin YH; Chi HC; Huang YH; Yang CC; Yeh CT; Tan BC; Lin KH
    Oncotarget; 2016 Apr; 7(16):22448-59. PubMed ID: 26968954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer.
    Ren P; Sun X; Zhang C; Wang L; Xing B; Du X
    Biochem Biophys Res Commun; 2019 May; 512(4):871-876. PubMed ID: 30929921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
    Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
    Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
    Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
    Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.